🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Moroctocog-alfa (AF-CC) is indicated for the control and prevention of hemo...
Status
Completed
Location
Nirmal Hospital
Start Date
2020-01-25
Trial ID
NCT04396639
Treatments Being Tested
This study is being conducted to compare how moroctocog alfa (AF-CC) acts i...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-08
Trial ID
NCT01579903
Treatments Being Tested
The study will be investigating pharmacokinetics, safety and efficacy in pa...
Status
Completed
Location
Kuopio University Hospital
Start Date
2009-12
Trial ID
NCT00914459
Treatments Being Tested
An open-label, single dose pharmacokinetic study of Xyntha (Moroctocog Alfa...
Status
Completed
Location
Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital
Start Date
2015-07
Trial ID
NCT02461992
Treatments Being Tested
An open-label, single-arm, post- authorization pragmatic clinical trial on ...
Status
Completed
Location
The Affiliated Hospital of Guizhou Medical University
Start Date
2015-04
Trial ID
NCT02492984
Treatments Being Tested
The purpose of this research study is to determine the effectiveness, safet...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2007-12
Trial ID
NCT00543439
Treatments Being Tested
The study will be investigating safety in patients who switch to ReFacto AF...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-05
Trial ID
NCT00884390
Treatments Being Tested
The purpose of this study is to collect safety information associated with ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00765726
Treatments Being Tested